nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimantadine—Ageusia—Vismodegib—skin cancer	0.0356	0.0356	CcSEcCtD
Rimantadine—Rigors—Vemurafenib—skin cancer	0.0218	0.0218	CcSEcCtD
Rimantadine—Cerebrovascular disorder—Fluorouracil—skin cancer	0.0188	0.0188	CcSEcCtD
Rimantadine—Rigors—Imiquimod—skin cancer	0.0186	0.0186	CcSEcCtD
Rimantadine—Cerebration impaired—Temozolomide—skin cancer	0.0155	0.0155	CcSEcCtD
Rimantadine—Gastrointestinal symptom NOS—Fluorouracil—skin cancer	0.0143	0.0143	CcSEcCtD
Rimantadine—Parosmia—Temozolomide—skin cancer	0.014	0.014	CcSEcCtD
Rimantadine—Cardiac failure—Imiquimod—skin cancer	0.0113	0.0113	CcSEcCtD
Rimantadine—Rigors—Temozolomide—skin cancer	0.0112	0.0112	CcSEcCtD
Rimantadine—Disturbance in attention—Temozolomide—skin cancer	0.0105	0.0105	CcSEcCtD
Rimantadine—Parosmia—Docetaxel—skin cancer	0.00934	0.00934	CcSEcCtD
Rimantadine—Gait disturbance—Temozolomide—skin cancer	0.00933	0.00933	CcSEcCtD
Rimantadine—Sweating increased—Imiquimod—skin cancer	0.00929	0.00929	CcSEcCtD
Rimantadine—Lacrimation increased—Fluorouracil—skin cancer	0.0091	0.0091	CcSEcCtD
Rimantadine—Dyspepsia—Vismodegib—skin cancer	0.00906	0.00906	CcSEcCtD
Rimantadine—Decreased appetite—Vismodegib—skin cancer	0.00895	0.00895	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Vismodegib—skin cancer	0.00888	0.00888	CcSEcCtD
Rimantadine—Fatigue—Vismodegib—skin cancer	0.00887	0.00887	CcSEcCtD
Rimantadine—Oedema peripheral—Vemurafenib—skin cancer	0.00882	0.00882	CcSEcCtD
Rimantadine—Constipation—Vismodegib—skin cancer	0.0088	0.0088	CcSEcCtD
Rimantadine—Depression—Imiquimod—skin cancer	0.00848	0.00848	CcSEcCtD
Rimantadine—Gastrointestinal pain—Vismodegib—skin cancer	0.00841	0.00841	CcSEcCtD
Rimantadine—Abdominal pain—Vismodegib—skin cancer	0.00813	0.00813	CcSEcCtD
Rimantadine—Chills—Vemurafenib—skin cancer	0.00803	0.00803	CcSEcCtD
Rimantadine—Mental disability—Temozolomide—skin cancer	0.0079	0.0079	CcSEcCtD
Rimantadine—Ageusia—Docetaxel—skin cancer	0.00748	0.00748	CcSEcCtD
Rimantadine—Rigors—Docetaxel—skin cancer	0.00742	0.00742	CcSEcCtD
Rimantadine—Asthenia—Vismodegib—skin cancer	0.00738	0.00738	CcSEcCtD
Rimantadine—Eye pain—Temozolomide—skin cancer	0.00732	0.00732	CcSEcCtD
Rimantadine—Euphoric mood—Fluorouracil—skin cancer	0.00721	0.00721	CcSEcCtD
Rimantadine—Tinnitus—Imiquimod—skin cancer	0.00712	0.00712	CcSEcCtD
Rimantadine—Diarrhoea—Vismodegib—skin cancer	0.00704	0.00704	CcSEcCtD
Rimantadine—Chills—Imiquimod—skin cancer	0.00685	0.00685	CcSEcCtD
Rimantadine—Cough—Vemurafenib—skin cancer	0.0068	0.0068	CcSEcCtD
Rimantadine—Bronchospasm—Bleomycin—skin cancer	0.00666	0.00666	CcSEcCtD
Rimantadine—Lacrimation increased—Docetaxel—skin cancer	0.00657	0.00657	CcSEcCtD
Rimantadine—Vomiting—Vismodegib—skin cancer	0.00654	0.00654	CcSEcCtD
Rimantadine—Rash—Vismodegib—skin cancer	0.00649	0.00649	CcSEcCtD
Rimantadine—Dermatitis—Vismodegib—skin cancer	0.00648	0.00648	CcSEcCtD
Rimantadine—Dysphagia—Dactinomycin—skin cancer	0.00632	0.00632	CcSEcCtD
Rimantadine—Cardiac failure—Fluorouracil—skin cancer	0.00624	0.00624	CcSEcCtD
Rimantadine—Ataxia—Temozolomide—skin cancer	0.00622	0.00622	CcSEcCtD
Rimantadine—Nausea—Vismodegib—skin cancer	0.00611	0.00611	CcSEcCtD
Rimantadine—Agitation—Imiquimod—skin cancer	0.0061	0.0061	CcSEcCtD
Rimantadine—Syncope—Imiquimod—skin cancer	0.00596	0.00596	CcSEcCtD
Rimantadine—Stomatitis—Bleomycin—skin cancer	0.00589	0.00589	CcSEcCtD
Rimantadine—Palpitations—Imiquimod—skin cancer	0.00587	0.00587	CcSEcCtD
Rimantadine—Loss of consciousness—Imiquimod—skin cancer	0.00584	0.00584	CcSEcCtD
Rimantadine—Cough—Imiquimod—skin cancer	0.0058	0.0058	CcSEcCtD
Rimantadine—Convulsion—Imiquimod—skin cancer	0.00576	0.00576	CcSEcCtD
Rimantadine—Hypertension—Imiquimod—skin cancer	0.00574	0.00574	CcSEcCtD
Rimantadine—Ataxia—Fluorouracil—skin cancer	0.00573	0.00573	CcSEcCtD
Rimantadine—Dysphagia—Temozolomide—skin cancer	0.00571	0.00571	CcSEcCtD
Rimantadine—Anxiety—Imiquimod—skin cancer	0.00564	0.00564	CcSEcCtD
Rimantadine—Sweating increased—Temozolomide—skin cancer	0.00557	0.00557	CcSEcCtD
Rimantadine—Dry mouth—Imiquimod—skin cancer	0.00553	0.00553	CcSEcCtD
Rimantadine—Decreased appetite—Vemurafenib—skin cancer	0.00553	0.00553	CcSEcCtD
Rimantadine—Stomatitis—Dactinomycin—skin cancer	0.00549	0.00549	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00549	0.00549	CcSEcCtD
Rimantadine—Fatigue—Vemurafenib—skin cancer	0.00548	0.00548	CcSEcCtD
Rimantadine—Constipation—Vemurafenib—skin cancer	0.00544	0.00544	CcSEcCtD
Rimantadine—Hypoaesthesia—Bleomycin—skin cancer	0.00539	0.00539	CcSEcCtD
Rimantadine—Shock—Imiquimod—skin cancer	0.00533	0.00533	CcSEcCtD
Rimantadine—Tachycardia—Imiquimod—skin cancer	0.00529	0.00529	CcSEcCtD
Rimantadine—Pollakiuria—Temozolomide—skin cancer	0.00528	0.00528	CcSEcCtD
Rimantadine—Dysphagia—Fluorouracil—skin cancer	0.00526	0.00526	CcSEcCtD
Rimantadine—Hyperhidrosis—Imiquimod—skin cancer	0.00524	0.00524	CcSEcCtD
Rimantadine—Anorexia—Imiquimod—skin cancer	0.00517	0.00517	CcSEcCtD
Rimantadine—Depression—Temozolomide—skin cancer	0.00508	0.00508	CcSEcCtD
Rimantadine—Stomatitis—Temozolomide—skin cancer	0.00497	0.00497	CcSEcCtD
Rimantadine—Insomnia—Imiquimod—skin cancer	0.0049	0.0049	CcSEcCtD
Rimantadine—Chills—Bleomycin—skin cancer	0.00486	0.00486	CcSEcCtD
Rimantadine—Dyspnoea—Imiquimod—skin cancer	0.00483	0.00483	CcSEcCtD
Rimantadine—Somnolence—Imiquimod—skin cancer	0.00482	0.00482	CcSEcCtD
Rimantadine—Dyspepsia—Imiquimod—skin cancer	0.00477	0.00477	CcSEcCtD
Rimantadine—Decreased appetite—Imiquimod—skin cancer	0.00471	0.00471	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Imiquimod—skin cancer	0.00468	0.00468	CcSEcCtD
Rimantadine—Fatigue—Imiquimod—skin cancer	0.00467	0.00467	CcSEcCtD
Rimantadine—Stomatitis—Fluorouracil—skin cancer	0.00458	0.00458	CcSEcCtD
Rimantadine—Asthenia—Vemurafenib—skin cancer	0.00456	0.00456	CcSEcCtD
Rimantadine—Hallucination—Temozolomide—skin cancer	0.00455	0.00455	CcSEcCtD
Rimantadine—Hypoaesthesia—Temozolomide—skin cancer	0.00455	0.00455	CcSEcCtD
Rimantadine—Chills—Dactinomycin—skin cancer	0.00454	0.00454	CcSEcCtD
Rimantadine—Oedema peripheral—Temozolomide—skin cancer	0.00451	0.00451	CcSEcCtD
Rimantadine—Cardiac failure—Docetaxel—skin cancer	0.0045	0.0045	CcSEcCtD
Rimantadine—Feeling abnormal—Imiquimod—skin cancer	0.00447	0.00447	CcSEcCtD
Rimantadine—Gastrointestinal pain—Imiquimod—skin cancer	0.00443	0.00443	CcSEcCtD
Rimantadine—Diarrhoea—Vemurafenib—skin cancer	0.00435	0.00435	CcSEcCtD
Rimantadine—Abdominal pain—Imiquimod—skin cancer	0.00429	0.00429	CcSEcCtD
Rimantadine—Tinnitus—Temozolomide—skin cancer	0.00426	0.00426	CcSEcCtD
Rimantadine—Dizziness—Vemurafenib—skin cancer	0.0042	0.0042	CcSEcCtD
Rimantadine—Hypoaesthesia—Fluorouracil—skin cancer	0.00419	0.00419	CcSEcCtD
Rimantadine—Ataxia—Docetaxel—skin cancer	0.00413	0.00413	CcSEcCtD
Rimantadine—Cough—Bleomycin—skin cancer	0.00412	0.00412	CcSEcCtD
Rimantadine—Chills—Temozolomide—skin cancer	0.0041	0.0041	CcSEcCtD
Rimantadine—Vomiting—Vemurafenib—skin cancer	0.00404	0.00404	CcSEcCtD
Rimantadine—Rash—Vemurafenib—skin cancer	0.00401	0.00401	CcSEcCtD
Rimantadine—Dermatitis—Vemurafenib—skin cancer	0.004	0.004	CcSEcCtD
Rimantadine—Headache—Vemurafenib—skin cancer	0.00398	0.00398	CcSEcCtD
Rimantadine—Asthenia—Imiquimod—skin cancer	0.00389	0.00389	CcSEcCtD
Rimantadine—Confusional state—Bleomycin—skin cancer	0.00388	0.00388	CcSEcCtD
Rimantadine—Dysphagia—Docetaxel—skin cancer	0.0038	0.0038	CcSEcCtD
Rimantadine—Nausea—Vemurafenib—skin cancer	0.00378	0.00378	CcSEcCtD
Rimantadine—Bronchospasm—Docetaxel—skin cancer	0.00374	0.00374	CcSEcCtD
Rimantadine—Tremor—Temozolomide—skin cancer	0.00373	0.00373	CcSEcCtD
Rimantadine—Diarrhoea—Imiquimod—skin cancer	0.00371	0.00371	CcSEcCtD
Rimantadine—Anorexia—Bleomycin—skin cancer	0.00367	0.00367	CcSEcCtD
Rimantadine—Agitation—Temozolomide—skin cancer	0.00366	0.00366	CcSEcCtD
Rimantadine—Dizziness—Imiquimod—skin cancer	0.00359	0.00359	CcSEcCtD
Rimantadine—Palpitations—Temozolomide—skin cancer	0.00352	0.00352	CcSEcCtD
Rimantadine—Cough—Temozolomide—skin cancer	0.00347	0.00347	CcSEcCtD
Rimantadine—Convulsion—Temozolomide—skin cancer	0.00345	0.00345	CcSEcCtD
Rimantadine—Vomiting—Imiquimod—skin cancer	0.00345	0.00345	CcSEcCtD
Rimantadine—Hypertension—Temozolomide—skin cancer	0.00344	0.00344	CcSEcCtD
Rimantadine—Dyspnoea—Bleomycin—skin cancer	0.00343	0.00343	CcSEcCtD
Rimantadine—Anorexia—Dactinomycin—skin cancer	0.00342	0.00342	CcSEcCtD
Rimantadine—Rash—Imiquimod—skin cancer	0.00342	0.00342	CcSEcCtD
Rimantadine—Dermatitis—Imiquimod—skin cancer	0.00342	0.00342	CcSEcCtD
Rimantadine—Headache—Imiquimod—skin cancer	0.0034	0.0034	CcSEcCtD
Rimantadine—Anxiety—Temozolomide—skin cancer	0.00338	0.00338	CcSEcCtD
Rimantadine—Decreased appetite—Bleomycin—skin cancer	0.00335	0.00335	CcSEcCtD
Rimantadine—Dry mouth—Temozolomide—skin cancer	0.00331	0.00331	CcSEcCtD
Rimantadine—Stomatitis—Docetaxel—skin cancer	0.0033	0.0033	CcSEcCtD
Rimantadine—Confusional state—Temozolomide—skin cancer	0.00328	0.00328	CcSEcCtD
Rimantadine—Nausea—Imiquimod—skin cancer	0.00322	0.00322	CcSEcCtD
Rimantadine—Convulsion—Fluorouracil—skin cancer	0.00318	0.00318	CcSEcCtD
Rimantadine—Feeling abnormal—Bleomycin—skin cancer	0.00317	0.00317	CcSEcCtD
Rimantadine—Hyperhidrosis—Temozolomide—skin cancer	0.00314	0.00314	CcSEcCtD
Rimantadine—Decreased appetite—Dactinomycin—skin cancer	0.00312	0.00312	CcSEcCtD
Rimantadine—Fatigue—Dactinomycin—skin cancer	0.0031	0.0031	CcSEcCtD
Rimantadine—Anorexia—Temozolomide—skin cancer	0.0031	0.0031	CcSEcCtD
Rimantadine—Hypoaesthesia—Docetaxel—skin cancer	0.00303	0.00303	CcSEcCtD
Rimantadine—Confusional state—Fluorouracil—skin cancer	0.00302	0.00302	CcSEcCtD
Rimantadine—Oedema peripheral—Docetaxel—skin cancer	0.003	0.003	CcSEcCtD
Rimantadine—Feeling abnormal—Dactinomycin—skin cancer	0.00296	0.00296	CcSEcCtD
Rimantadine—Insomnia—Temozolomide—skin cancer	0.00294	0.00294	CcSEcCtD
Rimantadine—Gastrointestinal pain—Dactinomycin—skin cancer	0.00294	0.00294	CcSEcCtD
Rimantadine—Tachycardia—Fluorouracil—skin cancer	0.00292	0.00292	CcSEcCtD
Rimantadine—Dyspnoea—Temozolomide—skin cancer	0.0029	0.0029	CcSEcCtD
Rimantadine—Somnolence—Temozolomide—skin cancer	0.00289	0.00289	CcSEcCtD
Rimantadine—Dyspepsia—Temozolomide—skin cancer	0.00286	0.00286	CcSEcCtD
Rimantadine—Anorexia—Fluorouracil—skin cancer	0.00285	0.00285	CcSEcCtD
Rimantadine—Abdominal pain—Dactinomycin—skin cancer	0.00284	0.00284	CcSEcCtD
Rimantadine—Decreased appetite—Temozolomide—skin cancer	0.00282	0.00282	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Temozolomide—skin cancer	0.00281	0.00281	CcSEcCtD
Rimantadine—Fatigue—Temozolomide—skin cancer	0.0028	0.0028	CcSEcCtD
Rimantadine—Constipation—Temozolomide—skin cancer	0.00278	0.00278	CcSEcCtD
Rimantadine—Asthenia—Bleomycin—skin cancer	0.00276	0.00276	CcSEcCtD
Rimantadine—Chills—Docetaxel—skin cancer	0.00273	0.00273	CcSEcCtD
Rimantadine—Insomnia—Fluorouracil—skin cancer	0.00271	0.00271	CcSEcCtD
Rimantadine—Feeling abnormal—Temozolomide—skin cancer	0.00268	0.00268	CcSEcCtD
Rimantadine—Dyspnoea—Fluorouracil—skin cancer	0.00267	0.00267	CcSEcCtD
Rimantadine—Somnolence—Fluorouracil—skin cancer	0.00266	0.00266	CcSEcCtD
Rimantadine—Gastrointestinal pain—Temozolomide—skin cancer	0.00266	0.00266	CcSEcCtD
Rimantadine—Dyspepsia—Fluorouracil—skin cancer	0.00264	0.00264	CcSEcCtD
Rimantadine—Decreased appetite—Fluorouracil—skin cancer	0.0026	0.0026	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00258	0.00258	CcSEcCtD
Rimantadine—Asthenia—Dactinomycin—skin cancer	0.00258	0.00258	CcSEcCtD
Rimantadine—Abdominal pain—Temozolomide—skin cancer	0.00257	0.00257	CcSEcCtD
Rimantadine—Feeling abnormal—Fluorouracil—skin cancer	0.00247	0.00247	CcSEcCtD
Rimantadine—Diarrhoea—Dactinomycin—skin cancer	0.00246	0.00246	CcSEcCtD
Rimantadine—Vomiting—Bleomycin—skin cancer	0.00245	0.00245	CcSEcCtD
Rimantadine—Rash—Bleomycin—skin cancer	0.00243	0.00243	CcSEcCtD
Rimantadine—Dermatitis—Bleomycin—skin cancer	0.00243	0.00243	CcSEcCtD
Rimantadine—Syncope—Docetaxel—skin cancer	0.00237	0.00237	CcSEcCtD
Rimantadine—Palpitations—Docetaxel—skin cancer	0.00234	0.00234	CcSEcCtD
Rimantadine—Asthenia—Temozolomide—skin cancer	0.00233	0.00233	CcSEcCtD
Rimantadine—Loss of consciousness—Docetaxel—skin cancer	0.00233	0.00233	CcSEcCtD
Rimantadine—Cough—Docetaxel—skin cancer	0.00231	0.00231	CcSEcCtD
Rimantadine—Convulsion—Docetaxel—skin cancer	0.00229	0.00229	CcSEcCtD
Rimantadine—Nausea—Bleomycin—skin cancer	0.00229	0.00229	CcSEcCtD
Rimantadine—Hypertension—Docetaxel—skin cancer	0.00229	0.00229	CcSEcCtD
Rimantadine—Vomiting—Dactinomycin—skin cancer	0.00228	0.00228	CcSEcCtD
Rimantadine—Rash—Dactinomycin—skin cancer	0.00226	0.00226	CcSEcCtD
Rimantadine—Diarrhoea—Temozolomide—skin cancer	0.00222	0.00222	CcSEcCtD
Rimantadine—Dry mouth—Docetaxel—skin cancer	0.0022	0.0022	CcSEcCtD
Rimantadine—Confusional state—Docetaxel—skin cancer	0.00218	0.00218	CcSEcCtD
Rimantadine—Dizziness—Temozolomide—skin cancer	0.00215	0.00215	CcSEcCtD
Rimantadine—Nausea—Dactinomycin—skin cancer	0.00213	0.00213	CcSEcCtD
Rimantadine—Shock—Docetaxel—skin cancer	0.00213	0.00213	CcSEcCtD
Rimantadine—Tachycardia—Docetaxel—skin cancer	0.00211	0.00211	CcSEcCtD
Rimantadine—Vomiting—Temozolomide—skin cancer	0.00207	0.00207	CcSEcCtD
Rimantadine—Anorexia—Docetaxel—skin cancer	0.00206	0.00206	CcSEcCtD
Rimantadine—Rash—Temozolomide—skin cancer	0.00205	0.00205	CcSEcCtD
Rimantadine—Diarrhoea—Fluorouracil—skin cancer	0.00205	0.00205	CcSEcCtD
Rimantadine—Dermatitis—Temozolomide—skin cancer	0.00205	0.00205	CcSEcCtD
Rimantadine—Headache—Temozolomide—skin cancer	0.00204	0.00204	CcSEcCtD
Rimantadine—Dizziness—Fluorouracil—skin cancer	0.00198	0.00198	CcSEcCtD
Rimantadine—Insomnia—Docetaxel—skin cancer	0.00195	0.00195	CcSEcCtD
Rimantadine—Nausea—Temozolomide—skin cancer	0.00193	0.00193	CcSEcCtD
Rimantadine—Dyspnoea—Docetaxel—skin cancer	0.00193	0.00193	CcSEcCtD
Rimantadine—Somnolence—Docetaxel—skin cancer	0.00192	0.00192	CcSEcCtD
Rimantadine—Vomiting—Fluorouracil—skin cancer	0.0019	0.0019	CcSEcCtD
Rimantadine—Dyspepsia—Docetaxel—skin cancer	0.0019	0.0019	CcSEcCtD
Rimantadine—Rash—Fluorouracil—skin cancer	0.00189	0.00189	CcSEcCtD
Rimantadine—Dermatitis—Fluorouracil—skin cancer	0.00189	0.00189	CcSEcCtD
Rimantadine—Decreased appetite—Docetaxel—skin cancer	0.00188	0.00188	CcSEcCtD
Rimantadine—Headache—Fluorouracil—skin cancer	0.00188	0.00188	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Docetaxel—skin cancer	0.00187	0.00187	CcSEcCtD
Rimantadine—Fatigue—Docetaxel—skin cancer	0.00186	0.00186	CcSEcCtD
Rimantadine—Constipation—Docetaxel—skin cancer	0.00185	0.00185	CcSEcCtD
Rimantadine—Feeling abnormal—Docetaxel—skin cancer	0.00178	0.00178	CcSEcCtD
Rimantadine—Nausea—Fluorouracil—skin cancer	0.00178	0.00178	CcSEcCtD
Rimantadine—Gastrointestinal pain—Docetaxel—skin cancer	0.00177	0.00177	CcSEcCtD
Rimantadine—Abdominal pain—Docetaxel—skin cancer	0.00171	0.00171	CcSEcCtD
Rimantadine—Asthenia—Docetaxel—skin cancer	0.00155	0.00155	CcSEcCtD
Rimantadine—Diarrhoea—Docetaxel—skin cancer	0.00148	0.00148	CcSEcCtD
Rimantadine—Dizziness—Docetaxel—skin cancer	0.00143	0.00143	CcSEcCtD
Rimantadine—Vomiting—Docetaxel—skin cancer	0.00137	0.00137	CcSEcCtD
Rimantadine—Rash—Docetaxel—skin cancer	0.00136	0.00136	CcSEcCtD
Rimantadine—Dermatitis—Docetaxel—skin cancer	0.00136	0.00136	CcSEcCtD
Rimantadine—Headache—Docetaxel—skin cancer	0.00135	0.00135	CcSEcCtD
Rimantadine—Nausea—Docetaxel—skin cancer	0.00128	0.00128	CcSEcCtD
